EGF and cancer: These cancers display mutations of the egfr gene in 4–14% of the cases, suggesting that AJ complex-mediated stabilization and genetic alteration may not represent mutually exclusive mechanisms to promote EGF signaling in cancer (Supplementary Fig. 8B).